Effect of Muscle Release Treatment in Patients Infected by Corona- Virus

Not Applicable

Recruiting

• Conditions: U07.1; COVID- 19.; COVID-19, virus identified

• Registration Number: IRCT20210214050356N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

With definitive diagnosis of Covid-19 (PCR test positive)
More than 6 months have passed since the onset of other acute diseases.
The patient does not have COPD or other respiratory diseases.

Exclusion Criteria

Body temperature over 38 degrees
The time of initial diagnosis or onset of symptoms is 3 days or less
The initial onset of dyspnea is 3 days or less
The chest image has improved by more than 50% in the last 24 to 48 hours
SpO2 90% or less
Blood pressure less than 90/60 mm Hg and more than 180/90 mm Hg
The number of breaths is more than 40 per minute
Heart rate less than 40 and more than 120 beats per minute
New onset of arrhythmia and myocardial ischemia
Moderate to severe heart disease (grade 3 or 4, according to the New York Heart Association)
with ischemic or hemorrhagic stroke or neurodegenerative diseases
Decreased level of consciousness
Reluctance to continue treatment and discharge with personal consent

Study & Design

• Study Type: interventional
• Study Design: Not specified